Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

NCT06026189 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06026189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06026189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safely Reduce Cystoscopic Evaluations for Hematuria Patients
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 31, 2023
Completion date
May 31, 2027
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria, urothelial carcinoma, urothelial neoplasm